Effect of shigru (Moringa oleifera Linn.) patra choorna tablet in the management of subclinical hypothyroidism- A single arm open labeled clinical trial
DOI:
https://doi.org/10.70066/jahm.v13i3.1621Keywords:
Subclincal hypothyroidism, single drug therapy, shigru, moringa, clinical studyAbstract
Background: Due to increasing global incidence of Thyroid disorders and their effect on day today life, numerous studies are being conducted to identify potential treatment for Anukta vyadhis. So many drugs have been known for Thyroid controlling properties; but researches regarding its clinical efficacy are less. Objectives: The purpose of this study was to evaluate the effectiveness of Shigru (Moringa oleifera Linn.) Patra churna tablet in the management of Subclinical Hypothyroidism. Materials & Methods: In this single arm open labeled clinical trial , all eligible participants were assigned to receive the intervention without randomization. Patients visiting Specialty OPD of KLE Ayurveda Hospital, Belgavi with signs & symptoms of Subclinical hypothyroidism like weight gain, hair-fall, edema, irregular menstrual cycle and 30 patients of 20 to 60 years age group of either sex without any history of Thyroid related disease, Diabetes Mellitus or Hypertension were included; TSH value above normal range but below 10 IU/L. Shigru patra churna tablet was given 1 gm twice a day before food for period of 42 days. The assessment of changes observed in Thyroid profile as well as in Anthropometrical changes like waist circumference and weight loss and clinical symptoms like Keshapatana (Hairfall), Medovriddhi(gradual weight loss), Shotha (Facial or generalized edema), Aniyamita artava (Menstrual disturbance), Klama (Lethargy or easy fatigue) was carried out. Results: After 42 days of intervention, Thyroid profile, especially TSH and other parameters were significantly decreased when compared with baseline. No adverse drug reaction was reported during and after the intervention with the use of study drug. Conclusion: Shigru patra churna was effective in the management of subclinical hypothyroidism and free from any adverse effect on patients.
References
REFERENCES-
Poppe, K., Bisschop, P., Fugazzola, L., Minziori, G., Unuane, D., & Weghofer, A. 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction. European Thyroid Journal[Internet]. 2021 Jan21 [cited 2024 Jun 11]; (281-295). Available from: https://doi.org/10.1159/000512790
Lee Goldman, Andrew Schaffer, Editor. Goldmans-Cecil medicine, 26th Ed, Elsevier saunders publisher, Vol II, 2020; 1465.
Vanderpump, M.P.J. Epidemiology of Thyroid Disorders 2019. In: Luster, M., Duntas, L., Wartofsky, L., Editor. The Thyroid and Its Diseases: Springer, Cham; January 2019; 75-85 https://doi.org/10.1007/978-3-319-72102-6_6
Loscalzo J, Fauci AS, Hauser S,Kasper D, J.Larry Jameson, Longo Dan. Mandel S, Anthony Weetman Antony Weetman, Editors. Harrison’s principles of Internal Medicine, 20th ed, New York:McGraw-Hill education;2022;2937
Sarita Bajaj, RV Jayakumar, Nihal Thomas, Sanjay Kalra, Rakesh Sahay, Editor. ESI Manual of Clinical Endocrinology, 2nd Ed, Jaypee Brothers Medical Publishers;2020;328
K C Chunekar. Bhavaprakash Nighantu (Commentry on Bhavaprakash Nighantu), Guduchyadi Varga. In: K C Chunekar, Editor. Varanasi : Chaukhambha Bharati Academy; 2015; 91-96
Kashinath Shastri, Gorakhnath Chaturvedi (editor). Charaka samhita of Charaka, Sutrasthana, chapter 4, verse no.13. Reprint 2019, Varanasi; Chaukhambha Bharati Academy; 2001:35
Alam MA, Quamri MA, Haider N. Efficacy and safety of Barg-e-Sahajna (Moringa oleifera Lam.) in primary hypothyroidism. Drug Metab Pers Ther. 2021 Aug 13;37(1):21-26. doi: 10.1515/dmpt-2021-0136. PMID: 34449175.
Vedavati, & Belavadi, S. N. (2023). Ayurvedic Management of Subclinical Hypothyroidism Vis-À-Vis Kaphavrita Udanavata – A Pilot Study. International Research Journal of Ayurveda & Yoga, 6(10), 33-37
Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. J Altern Complement Med. 2018 Mar;24(3):243-248. doi: 10.1089/acm.2017.0183. Epub 2017 Aug 22. PMID: 28829155.
Pearce, S. H., Brabant, G. Duntas, L. H. Monzani, F. Peeters, R. P. Razvi, S., Wemeau, J. et al. (2013). 2013 ETA Guideline: Management of Subclinical Hypothyroidism. European Thyroid Journal 2013; vol 2, issue 4:215-228 https://doi.org/10.1159/000356507
Jonklaas, J., Bianco A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., Sawka, A. M. et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 2014; vol 24, no 12:1670–1751 https://doi.org/10.1089/thy.2014.0028
Vasant Patil (editor). Sushruta samhita of Sushruta, chapter 36, verse no.5. 1st edition,New Delhi; Chaukhambha Publication;2018:376
Pankaj Tahiliani, Anand Kar, role of Moringa oleifera leaf extract in the regulation of thyroid hormone status in adult male and female rats, Pharmacological Research, Volume 41, Issue 3, 2000, Pages 319-323, ISSN 1043-6618, https://doi.org/10.1006/phrs.1999.0587.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Shubham Koundalkar; Dr. Arun C
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author(s) will retain copyright and permit the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that permits others to share the work with an acknowledgment of the author and initial publication in this journal.
The entire contents of the JAHM are protected under Indian and international copyrights. The Journal, however, allows free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute works in any online website for any non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also permits the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
In case of JAHM does not publish said work, the author(s) will be so notified and all rights assigned hereunder will be given back to the author(s).
All accepted works should not be published anywhere without prior written permission from JAHM. The author(s) hereby declare that they are sole author(s) of the work, that all authors have contributed and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work has been submitted to another journal.
